Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Paxman ABPXMBF 75 EV-to-OCF is -455.16 as of Aug. 09, 2026. GuruFocus rates PXMBF with a GF Score™ of 75/100 and a GF Value™ of $4.61. The stock has 3 warning signs investors should review. Among 853 Medical Devices & Instruments companies, Paxman AB ranks better than 98.94% on this metric.
EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, Paxman AB's Enterprise Value is $106.96 Mil.
Paxman AB's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 was $-0.24 Mil. Therefore, Paxman AB's EV-to-OCF for today is -455.16.
The historical rank and industry rank for Paxman AB's EV-to-OCF or its related term are showing as below:
PXMBF'
s EV-to-OCF Range Over the Past 10 Years
Min: -538.61 Med: 45.05 Max: 1820.27
Current: -455.66
During the past 9 years, the highest EV-to-OCF of Paxman AB was 1820.27. The lowest was -538.61. And the median was 45.05.
PXMBF's EV-to-OCF is ranked better than 98.94% of 853
companies
in the Medical Devices & Instruments industry
Industry Median: 7.82
vs PXMBF: -455.66
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Paxman AB's share price for today is $3.50.
Paxman AB's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.052.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Paxman AB EV-to-OCF Related Terms
Paxman AB EV-to-OCF Historical Data
* Premium members only.
The historical data trend for Paxman AB's EV-to-OCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Paxman AB's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Paxman AB EV-to-OCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Paxman AB's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where Paxman AB's EV-to-OCF falls into.
Paxman AB's current Enterprise Value is $106.96 Mil.
Paxman AB's Cash Flow from Operations for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.24 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Paxman AB (PXMBF) has a EV-to-OCF of -455.16 as of Aug. 09, 2026. According to the industry distribution chart, Paxman AB ranks #9 out of 853 companies in the Medical Devices & Instruments industry, placing it in the top 1.1%.
Is Paxman AB's EV-to-OCF too high?
Paxman AB's current EV-to-OCF is -455.16. Based on the distribution chart, Paxman AB ranks #9 out of 853 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Paxman AB has a GF Score™ of 75/100, reflecting its overall financial health beyond just this single metric.
How does Paxman AB's EV-to-OCF compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Paxman AB ranks #9 out of 853 companies for EV-to-OCF. This places Paxman AB in the top 1% of its industry — outperforming the majority of peers. The industry median EV-to-OCF is 7.82. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Medical Devices & Instruments company?
The median EV-to-OCF among Medical Devices & Instruments companies is 7.82, based on 853 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-OCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median EV-to-OCF is 7.82 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Paxman AB's current EV-to-OCF is -455.16. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Paxman AB stock overvalued right now?
Paxman AB (PXMBF) has a current EV-to-OCF of -455.16. The stock's GF Value™ is $4.61, compared to a current price of $3.50 — trading 24.1% below its estimated fair value. The current EV-to-OCF is -455.16. Paxman AB's overall GF Score™ is 75/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For Paxman AB (PXMBF), the current EV-to-OCF is -455.16 as of Aug. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Paxman AB (PXMBF) Overvalued in 2026?
Based on GuruFocus' analysis, Paxman AB stock appears to be undervalued.
The current stock price of $3.50 is trading 24.1% below its estimated GF Value™ of $4.61.
Key valuation signals for PXMBF:
EV-to-OCF: -455.16
GF Value™: $4.61 vs. price of $3.50 (24.1% below fair value)
No single metric tells the full story. See the PXMBF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Paxman AB is a Sweden-based company engaged in the development of the PAXMAN Scalp Cooling System, which has been developed by the Paxman family to reduce hair loss in breast cancer patients undergoing chemotherapy. The portfolio includes both the Paxman and Digni Capsystems with several installations in hospitals, clinics, and treatment centres world-wide.
75GF Score
Get the complete analysis for PXMBF
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PXMBF has been successfully added to your 
